Nanoco Group Plc
NANO:LN
Latest Coverage
Overview
Company Profile
Nanoco leads the world in the research, development and large-scale manufacture of heavy-metal free quantum dots and semiconductor nanoparticles for use in displays, lighting, solar energy and bio-imaging.
Classification
Financials
News & Media
Corporate
Board of Directors
Anthony Clinch
Non-Executive Chairman
Anthony Clinch, former chairman of the advisory board of CABB International GmbH, an international manufacturer of fine and intermediate chemicals, chairman of the Valence Group an international specialist investment bank and senior advisor to CVC Capital Partners. He was an employee of CVC Capital Partners between 1987 and 2007 and was responsible for, and a non-executive director of a number of CVC Capital Partners’ international chemical investments. He previously worked for Citibank in several managerial roles in Corporate Banking. He is a chartered engineer and a member of the Institution of Engineering and Technology, having spent his early career with Rolls Royce Ltd. He holds an M.Sc. in Management Science and Operational Research and a BSc. in Aeronautical Engineering from Imperial College.
Dr Michael Edelman
CEO
Nanoco is led by Michael Edelman. Michael joined Nanoco in 2004, led the initial fund–raising and spun Nanoco out of the University of Manchester. Prior to Nanoco, Michael held a number of executive roles including responsibility for licensing the technology developed by GE/Bayer joint venture, Exatec LLP, Vice President and Managing Director at yet2.com , Commercial Director at Colloids Ltd and Business Manager at Brunner Mond & Co ltd., Michael started his career with ICI, has a Ph.D. in organo–metallic chemistry from the University of Sussex, UK, and undergraduate degree in classics and chemistry from Tufts University, Boston, MA, USA.
Mark Sullivan
Interim CFO
Mark Sullivan was appointed as interim Chief Financial Officer of the Company in October 2014. Mark is a Fellow of the Chartered Association of Certified Accountants and has provided accountancy services to Nanoco as a partner of Summ.It Assist LLP for the past 10 years. Prior to the reverse acquisition of Nanoco Tech Limited by Evolutec Group plc in April 2009, Mark acted as Head of Finance and thereafter acted in a supporting role to the Company’s Chief Financial Officers. After qualifying whilst working in an accountancy practice, Mark had several senior roles in industry, including the privatisation of Greater Manchester Buses North and in its subsequent sale to FirstGroup plc and finally as Finance Director of a major subsidiary of FirstGroup plc. Mark was appointed as a temporary replacement for the Group’s former CFO, Colin White, who resigned on 31 December 2014 due to health reasons.
Dr Nigel Pickett
CTO
Nanoco’s technology team is led by Nigel Pickett who is a co–founder of Nanoco and inventor of Nanoco’s key quantum dot scale–up technology. Nigel graduated from Newcastle University in 1991 and chose to remain at Newcastle to pursue a Ph.D. in the field of main group organo-metallics. After graduation in 1994 he undertook a postdoctoral fellowship at St. Andrews University, Scotland, in the field of precursor design for MOVPE growth and synthesis of nanoparticles using CVD techniques. In 1996 he won a Japan Society for the Promotion of Science (JSPS) fellowship and spent the following year working at Tokyo University of Agriculture and Technology, Japan. In 1998 he became a research fellow at Georgia Institute of Technology, USA, working on the design and evaluation of precursor used in MOVPE. Nigel co–founded Nanoco Technologies in 2001.
Keith Wiggins
COO
Keith is a highly experienced chemicals industry executive. He began his career with ICI, working in R&D and manufacturing, before joining The Dow Chemical Company (“Dow”) in 1989 as a sales manager in its London office. He went on to lead progressively bigger and more complex specialty chemical businesses around the world, living in Germany, Switzerland and the USA. In 2006 Keith returned to the UK as Managing Director for Dow UK, Ireland & Nordic. He held this position until 2013 and, from 2006 to 2011, he was concurrently CEO-Global Business Director of Haltermann, a specialty chemicals subsidiary of Dow. Keith, who graduated in chemistry at Imperial College, London, is an Honorary Fellow of the Royal Society of Chemistry. He has held a number of industry offices including President of the Chemical Industries Association between 2011 and 2013.
Gordon Hall
Non-Executive Director
After an early career in teaching, Gordon built up substantial international sales, management and development expertise with Rank Xerox and Abbott Laboratories. He became Chief Executive Officer of Shield Diagnostic Limited (subsequently Axis Shield PLC) in 1990 and was responsible for listing the company on the London Stock Exchange. More recently Gordon has been involved with a range of different companies and he is currently a non–executive Director of EKF Diagnostics plc and of Quoram plc, both of which are listed on AIM.
Dr Peter Rowley
Non-Executive Director
Peter Rowley joined the Nanoco board in 2006. Previously he led the management buyout of Victrex from ICI in 1993, followed by the successful listing of Victrex PLC on the London Stock Exchange in 1995. He joined ICI in 1968 and progressed through a number of positions in the organisation. In 1983 he became International Business Manager for the widely used polymer PTFE and in 1989 he was appointed General Manager for ICI Advanced Materials Asia Pacific. Peter has a Ph.D. in organic chemistry from King’s College London.
Robin Williams
Non-Executive Director
Robin qualified as an accountant in 1981 after graduating in engineering science. He worked in corporate finance for ten years at investment banks including Salomon Brothers and UBS before leaving the City in 1992 to co-found the packaging business Britton Group plc. In 1998, he moved to Hepworth plc, the building materials group, and since 2004 he has focused on non-executive work in public, private and PE-backed businesses.